Loading...

Yiwey Shieh, MD

Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
Address1545 Divisadero Street
San Francisco CA 94115
Phone--
ORCID ORCID Icon0000-0002-0159-7748 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Harvard UniversityAB2006Biology
    University of California, San FranciscoMD2012School of Medicine
    Hospital of the University of PennsylvaniaResidency2015Internal Medicine - Primary Care
    University of California, San FranciscoMAS2017Clinical Research
    Collapse Awards and Honors
    UCSF Breast Oncology Program2017Best Poster, Epidemiology and Population Science
    Society of General Internal Medicine2017Finalist, Mack Lipkin Sr. Associate Member Scientific Presentation Award
    Society of General Internal Medicine2018Winner, Milton W. Hamolsky Junior Faculty Scientific Presentation Award

    Collapse Overview 
    Collapse Overview
    Yiwey Shieh, MD is an Assistant Professor in the Department of Medicine at the University of California, San Francisco (UCSF). Dr. Shieh is a general internist and clinical epidemiologist interested in improving the delivery of breast cancer screening and prevention through the use of risk stratification tools. His current work uses clinical risk factors, breast density, and genetic variants to refine individualized risk assessment, especially as it pertains to disease biology. As a clinician-investigator, he is particularly interested in how such tools can be used to improve clinical decision-making.

    Collapse Research 
    Collapse Research Activities and Funding
    Prediction of interval breast cancer risk using genetic variants
    NIH K08CA237829Jul 1, 2019 - Jun 30, 2024
    Role: Principal Investigator
    UCSF CTSI KL2 Career Development Award
    NIH/NCATS 1KL2TR001870Jun 1, 2018 - Jun 30, 2019
    Role: KL2 Scholar

    Collapse ORNG Applications 
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Medications for Primary Prevention of Breast Cancer. JAMA. 2020 07 21; 324(3):291-292. Shieh Y, Tice JA. PMID: 32692377.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    2. A Polygenic Risk Score for Breast Cancer in US Latinas and Latin American Women. J Natl Cancer Inst. 2020 Jun 01; 112(6):590-598. Shieh Y, Fejerman L, Lott PC, Marker K, Sawyer SD, Hu D, Huntsman S, Torres J, Echeverry M, Bohórquez ME, Martínez-Chéquer JC, Polanco-Echeverry G, Estrada-Flórez AP, Haiman CA, John EM, Kushi LH, Torres-Mejía G, Vidaurre T, Weitzel JN, Zambrano SC, Carvajal-Carmona LG, Ziv E, Neuhausen SL. PMID: 31553449.
      View in: PubMed   Mentions: 5     Fields:    
    3. Interval breast cancers - insights into a complex phenotype. Nat Rev Clin Oncol. 2020 03; 17(3):138-139. Shieh Y, Ziv E, Kerlikowske K. PMID: 31965086.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype. Breast Cancer Res. 2019 04 03; 21(1):48. Shieh Y, Scott CG, Jensen MR, Norman AD, Bertrand KA, Pankratz VS, Brandt KR, Visscher DW, Shepherd JA, Tamimi RM, Vachon CM, Kerlikowske K. PMID: 30944014.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    5. A response to "Personalised medicine and population health: breast and ovarian cancer". Hum Genet. 2019 Mar; 138(3):287-289. Antoniou A, Anton-Culver H, Borowsky A, Broeders M, Brooks J, Chiarelli A, Chiquette J, Cuzick J, Delaloge S, Devilee P, Dorval M, Easton D, Eisen A, Eklund M, Eloy L, Esserman L, Garcia-Closas M, Goldgar D, Hall P, Knoppers BM, Kraft P, La Croix A, Madalensky L, Mavaddat N, Mittman N, Nabi H, Olopade O, Pashayan N, Schmidt M, Shieh Y, Simard J, Stover-Fiscallini A, Tice JA, Van't Veer L, Wenger N, Wolfson M, Yau C, Ziv E. PMID: 30810870.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    6. A breast cancer risk model as a predictor of interval cancer rate and tumor characteristics. Journal of Clinical Oncology. 2018 May 20; 36(15_suppl):1506-1506. Nickolas Dreher, Irene Acerbi, Edward Kenji Hadeler, Yiwey Shieh, Michelle E. Melisko, Athena Investigators and Advocates, Laura Esserman, Laura van 't Veer. .
      View in: Publisher Site   Mentions:
    7. The WISDOM Study: breaking the deadlock in the breast cancer screening debate. NPJ Breast Cancer. 2017; 3:34. Esserman LJ. PMID: 28944288.
      View in: PubMed   Mentions:
    8. Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones. Breast Cancer Res Treat. 2017 Nov; 166(2):603-612. Shieh Y, Hu D, Ma L, Huntsman S, Gard CC, Leung JWT, Tice JA, Ziv E, Kerlikowske K, Cummings SR. PMID: 28791495.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    9. Low-Dose CT Scan for Lung Cancer Screening: Clinical and Coding Considerations. Chest. 2017 07; 152(1):204-209. Shieh Y, Bohnenkamp M. PMID: 28336485.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    10. Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial. J Natl Cancer Inst. 2017 01; 109(5). Shieh Y, Eklund M, Madlensky L, Sawyer SD, Thompson CK, Stover Fiscalini A, Ziv E, Van't Veer LJ, Esserman LJ, Tice JA. PMID: 28130475.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    11. Breast cancer risk prediction using a clinical risk model and polygenic risk score. Breast Cancer Res Treat. 2016 Oct; 159(3):513-25. Shieh Y, Hu D, Ma L, Huntsman S, Gard CC, Leung JW, Tice JA, Vachon CM, Cummings SR, Kerlikowske K, Ziv E. PMID: 27565998.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    12. Population-based screening for cancer: hope and hype. Nat Rev Clin Oncol. 2016 09; 13(9):550-65. Shieh Y, Eklund M, Sawaya GF, Black WC, Kramer BS, Esserman LJ. PMID: 27071351.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansPHPublic Health
    13. Detection of ductal carcinoma in situ and subsequent interval cancers. BMJ. 2016 Feb 01; 352:i551. Shieh Y, Eklund M, Esserman L. PMID: 26834245.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Impact of mammographic screening on the detection of good and poor prognosis breast cancers. Breast Cancer Res Treat. 2011 Dec; 130(3):725-34. Esserman LJ, Shieh Y, Rutgers EJ, Knauer M, Retèl VP, Mook S, Glas AM, Moore DH, Linn S, van Leeuwen FE, van 't Veer LJ. PMID: 21892702.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    15. Characterizing the impact of 25 years of DCIS treatment. Breast Cancer Res Treat. 2011 Aug; 129(1):165-73. Ozanne EM, Shieh Y, Barnes J, Bouzan C, Hwang ES, Esserman LJ. PMID: 21390494.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansPHPublic Health
    16. Effect of screening on the detection of good and poor prognosis breast cancers. Journal of Clinical Oncology. 2010 May 20; 28(15_suppl):1520-1520. Y. Shieh, L. Esserman, E. J. Rutgers, M. Knauer, V. Retel, S. Mook, A. Glas, S. C. Linn, F. E. van Leeuwen, L. van't Veer. .
      View in: Publisher Site   Mentions:
    17. Rethinking screening for breast cancer and prostate cancer. JAMA. 2009 Oct 21; 302(15):1685-92. Esserman L, Shieh Y, Thompson I. PMID: 19843904.
      View in: PubMed   Mentions: 160     Fields:    Translation:HumansPHPublic Health
    18. A role for biomarkers in the screening and diagnosis of breast cancer in younger women. Expert Rev Mol Diagn. 2007 Sep; 7(5):533-44. Esserman LJ, Shieh Y, Park JW, Ozanne EM. PMID: 17892362.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans